20 results
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
13 Oct 20
Report of Foreign Private Issuer
9:30am
of (a) radiographic infiltrates by imaging (chest x-ray, CT scan, etc.), or (b) Sp/O2 ratio lower or equal to 94% on room air, or (c) requiring … -ray, CT scan, etc.), or (b) Sp/O2 ratio lower or equal to 94% on room air, or (c) requiring supplemental oxygen (low flow or high flow), with a P/F
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
22 Oct 20
Enlivex Reports Dosing of First Two Patients in Phase II Clinical Trial Evaluating Allocetra in Severe and Critical COVID-19 Patients
8:49am
-ray, CT scan, etc.), or (b) Sp/O2 ratio lower or equal to 94% on room air, or (c) requiring supplemental oxygen (low flow or high flow), with a P/F
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
27 Oct 20
Report of Foreign Private Issuer
8:03am
-ray, CT scan, etc.), or (b) Sp/O2 ratio lower or equal to 94% on room air, or (c) requiring supplemental oxygen (low flow or high flow), with a P/F
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
3 Dec 20
Enlivex Reports Positive Interim Results From Phase II Clinical Trial Evaluating Allocetra in Severe and Critical COVID-19 Patients
8:00am
or equal to 94% on room air, or (c) requiring supplemental oxygen (low flow or high flow), with a P/F ratio of below 350 but higher than 150. Exclusion
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
3 Feb 21
Current Report
7:55am
or equal to 93% on room air, or (c) requiring supplemental oxygen (low flow or high flow), with a P/F ratio of below 350 but higher than 150
6-K
EX-10.1
ay8 yr7gwp
22 Oct 20
Report of Foreign Private Issuer
8:47am
6-K
EX-99.1
av0okbcf75vgtdas
19 Nov 18
Agreement and Plan of Merger
4:34pm
6-K
EX-1.1
asfwz
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
6-K
EX-99.1
edsh5 dhef5
19 May 20
Annual and Extraordinary General Meeting of Shareholders
8:04am
6-K
EX-1.1
wq1uebisec
5 Mar 20
Report of Foreign Private Issuer
8:16am
6-K
EX-10.1
wqzoerusmfonwgbvx
30 Dec 22
Report of Foreign Private Issuer
4:02pm
6-K
EX-1.1
i67m5
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
6-K
EX-99.2
qv62qnqfs
6 Dec 18
Amended Notice of Annual and Extraordinary General Meeting of the Shareholders
4:43pm
- Prev
- 1
- Next